FDG-PET. A possible prognostic factor in head and neck cancer

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Previous research links high (18)F-fluoro-2-deoxy-glucose (FDG) uptake in head and neck cancers to poorer survival.
• The prognostic significance of standardized uptake value (SUV) requires further confirmation.

Purpose of the Study:

• To confirm the association between high FDG uptake (SUV) and survival in head and neck squamous cell carcinoma.
• To determine if SUV has independent prognostic value.

Main Methods:

• Seventy-three patients with newly diagnosed head and neck squamous cell carcinoma underwent pre-treatment positron emission tomography (PET) scans.
• Standardized uptake value (SUV), tumor stage, diameter, and other clinical factors were analyzed for prognostic significance.
• Univariate and multivariate analyses were performed, with an SUV of 10 used as a cutoff for high/low uptake.

Main Results:

• Higher tumor stage, diameter, and SUV were associated with decreased survival in univariate analysis.
• An SUV greater than 10 was a significant predictor of worse outcome (P=0.003).
• Multivariate analysis confirmed SUV > 10 as an independent prognostic factor (P=0.002), regardless of tumor stage and diameter.

Conclusions:

• High FDG uptake (SUV > 10) on PET scans is a significant marker for poor prognosis in primary head and neck squamous cell carcinoma.
• SUV may help identify aggressive tumors and patients who could benefit from intensified treatment protocols.
• This finding supports the use of SUV in treatment stratification for head and neck cancer.